Califf: Not Wise To Create Problems Related to Chinese Pharma Supply Chain Dependence

 
• By Sarah Karlin-Smith

The US FDA Commissioner pushed for rebalancing the US’s pharmaceutical supply chains while also stressing that US-China commerce has a role that would be risky to compromise. 

scale with earth on one side and businessman holding circle graph divided into various segments on the other side
FDA Commissioner Robert Califf wants to decrease US reliance on China, without eliminating its relationship with the country. • Source: Shutterstock

More from Distribution/Supply Chain

More from Compliance